Hsinchu County, Taiwan

Kung-Lung Lee


 

Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Hepatitis B Therapeutics by Kung-Lung Lee

Introduction

Kung-Lung Lee is a notable inventor based in Hsinchu County, Taiwan. He has made significant contributions to the field of medical science, particularly in the development of therapeutic vaccines for hepatitis B. His innovative approach combines various protein domains to enhance the efficacy of vaccines.

Latest Patents

Kung-Lung Lee holds a patent for a hepatitis B therapeutic vaccine. This patent describes a fusion protein designed for use as a therapeutic vaccine against hepatitis B. The fusion protein includes an antigen-presenting cell (APC)-binding domain or a CD91 receptor-binding domain, a protein transduction domain, and an antigen that comprises a hepatitis B virus X protein deletion mutant. The protein transduction domain is a fusion polypeptide that consists of a T cell sensitizing signal-transducing peptide, a linker, and a translocation peptide. The APC-binding domain or the CD91 receptor-binding domain is positioned at the N-terminus of the fusion protein, while the antigen is located at the C-terminus of the protein transduction domain. This innovative design aims to improve the immune response against hepatitis B.

Career Highlights

Kung-Lung Lee is associated with Thevax Genetics Vaccine Co., Ltd., where he continues to work on advancing vaccine technology. His research focuses on creating effective solutions for viral infections, particularly hepatitis B. His dedication to innovation in the field of immunology has positioned him as a key figure in vaccine development.

Collaborations

Kung-Lung Lee collaborates with esteemed colleagues such as Chia-Mao Wu and Jiun-Ming Wu. Their combined expertise contributes to the advancement of therapeutic strategies in the fight against hepatitis B.

Conclusion

Kung-Lung Lee's work in developing a hepatitis B therapeutic vaccine showcases his commitment to innovation in medical science. His contributions are vital in the ongoing battle against viral infections, and his patent reflects a significant step forward in vaccine technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…